Recent clinical evidence supports a link between 25-hydroxyvitamin D insufficiency (serum 25-hydroxyvitamin D [25(OH)D] levels <30 ng/mL) and Parkinson's disease. To investigate the effect of 25(OH)D depletion on neuronal susceptibility to toxic insult, we induced a state of 25(OH)D deficiency in mice and then challenged them with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We found there was no significant difference between control and 25(OH)D-deficient animals in striatal dopamine levels or dopamine transporter and tyrosine hydroxylase expression after lesioning with MPTP. Additionally, we found no difference in tyrosine hydroxylase expression in the substantia nigra pars compacta. Our data suggest that reducing 25(OH)D serum levels in mice has no effect on the vulnerability of nigral dopaminergic neurons in vivo in this model system of parkinsonism.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388077 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039227 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial.
PLoS Med
December 2023
Liggins Institute, University of Auckland, Auckland, New Zealand.
Article Synopsis
- Maternal vitamin status before and during pregnancy significantly impacts pregnancy outcomes and offspring development, but there is limited longitudinal data on how it changes from preconception through postpartum.
- The NiPPeR trial involved 1,729 women who were randomized to receive either a standard or enhanced vitamin supplement from preconception to 6 months postpartum, evaluating the effects on vitamin status and glucose tolerance during pregnancy.
- Key findings focused on the primary outcome of glucose tolerance at 28 weeks and a secondary outcome related to reducing maternal micronutrient insufficiencies in vitamins B6, B12, riboflavin, and D during pregnancy.
Effect of high dose vitamin D on the HIV-1 reservoir: A pilot randomised controlled trial.
J Virus Erad
September 2023
Victorian Infectious Diseases Service, The Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria, 3000, Australia.
Introduction: Antiretroviral therapy for people living with HIV-1 must be taken lifelong due to the persistence of latent virus in long-lived and proliferating CD4 T cells. Vitamin D is a steroidal gene transcription regulator which exerts diverse effects on immune and epithelial cells including reductions in CD4 T cell proliferation and improvement in gut barrier integrity. We hypothesised that a high dose of vitamin D would reduce the size of the HIV-1 reservoir by reducing CD4 T cell proliferation.
View Article and Find Full Text PDFImproved quantitative LC-MS/MS analysis of vitamin D metabolites in serum after one-pot double derivatization.
J Pharm Biomed Anal
September 2023
Department of Chemistry, Humboldt Universität zu Berlin, Brook-Taylor Str. 2, Berlin 12489, Germany. Electronic address:
In this study, we report a one-pot double derivatization scheme, which used acetylation after a Diels-Alder reaction using 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) to improve separation efficiency and provide baseline separations of the five vitamin D metabolites 1,25-dihydroxyvitamin D (1,25(OH)D), 24,25-dihydroxyvitamin D3 (24,25(OH)D), 3β-25-hydroxyvitamin D (3β-25(OH)D), 3α-25-hydroxyvitamin D (3α-25(OH)D) and vitamin D on a C-18 stationary phase. Vitamin D metabolites are often very challenging to measure quantitatively using mass spectrometry, due to their low serum concentration levels and low ionization efficiencies. Moreover, some of these species are isomers with virtually identical mass spectral dissociation behavior.
View Article and Find Full Text PDFPrevalence of Vitamin D Deficiency in Patients Treated for Juvenile Idiopathic Arthritis and Potential Role of Methotrexate: A Preliminary Study.
Nutrients
April 2022
Department of Pediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, Waszyngtona Street 17, 15274 Bialystok, Poland.
Article Synopsis
- * The study found that higher doses of methotrexate (MTX) are associated with lower vitamin D levels, whereas glucocorticoid (GC) treatment did not show the same correlation.
- * The researchers suggest that all JIA patients, especially those on long-term MTX, should consider vitamin D supplementation to address this deficiency.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!